Stay updated on KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer
Sign up to get notified when there's something new on the KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer page.

Latest updates to the KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer page
- CheckyesterdayChange DetectedRevision: v3.5.4 was added and Revision: v3.5.3 was removed, reflecting a version update on the page. This metadata change updates the page's revision number but does not modify the study content.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now displays Revision: v3.5.3, replacing the previous v3.5.2. This marks a new version of the page metadata rather than a substantive update to study details.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 on the page.SummaryDifference0.1%

- Check58 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check65 days agoChange DetectedUpdated site revision from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check94 days agoChange DetectedAdded Revision: v3.4.2 tag and removed the previous government-funding/operating-status notices, while core study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

Stay in the know with updates to KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer
Enter your email address, and we'll notify you when there's something new on the KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer page.